Search

Factors influencing the efficacy of recombinant tissue plasminogen activator: Implications for ischemic stroke treatment

메타 데이터

바이오화학분류
    • 의료용 화학소재
      1. 치료제
논문

Factors influencing the efficacy of recombinant tissue plasminogen activator: Implications for ischemic stroke treatment

학술지

PLoS ONE

저자명

Ví teč ek, Jan; Ví teč ková Wü nschová , Andrea; Thalerová , Sandra; Gulati, Sumeet; Kubala, Luká š Capandová , Michaela; Hampl, Aleš Robert Mikulí k,

초록

<P>Intravenous thrombolysis with a recombinant tissue plasminogen activator (rt-PA) is the first-line treatment of acute ischemic stroke. However, successful recanalization is relatively low and the underlying processes are not completely understood. The goal was to provide insights into clinically important factors potentially limiting rt-PA efficacy such as clot size, rt-PA concentration, clot age and also rt-PA in combination with heparin anticoagulant. We established a static <I>in vitro</I> thrombolytic model based on red blood cell (RBC) dominant clots prepared using spontaneous clotting from the blood of healthy donors. Thrombolysis was determined by clot mass loss and by RBC release. The rt-PA became increasingly less efficient for clots larger than 50 &mu;l at a clinically relevant concentration of 1.3 mg/l. A tenfold decrease or increase in concentration induced only a 2-fold decrease or increase in clot degradation. Clot age did not affect rt-PA-induced thrombolysis but 2-hours-old clots were degraded more readily due to higher activity of spontaneous thrombolysis, as compared to 5-hours-old clots. Finally, heparin (50 and 100 IU/ml) did not influence the rt-PA-induced thrombolysis. Our study provided <I>in vitro</I> evidence for a clot size threshold: clots larger than 50 &mu;l are hard to degrade by rt-PA. Increasing rt-PA concentration provided limited thrombolytic efficacy improvement, whereas heparin addition had no effect. However, the higher susceptibility of younger clots to thrombolysis may prompt a shortened time from the onset of stroke to rt-PA treatment.</P>

발행연도

2024

발행기관

Public Library of Science

ISSN

1932-6203

19

6

페이지

pp.e0302269

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

논문; 2024-01-01

Export

About

Search

Trend